Physician profile
Paul E Salem
NPI 1831621002
$11,471.06
in general payments reported to CMS, 2019-2025
11 companies · $8,001 in 2025
The $8,001 reported for 2025 was more than what 94% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $1,029 · 2023: $275 · 2024: $2,166 · 2025: $8,001.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Education: $5,500 · Travel and Lodging: $3,378 · Food and Beverage: $1,564.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Education | $5,500.00 |
| Travel and Lodging | $3,377.71 |
| Food and Beverage | $1,564.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $8,490.79 | 2022-2025 | |
| Medtronic, INC. | $1,948.86 | 2023-2025 | Ligasure, Signia |
| Shield Therapeutics INC | $282.64 | 2024 | |
| Novo Nordisk INC | $246.91 | 2023-2025 | Wegovy |
| Lilly USA, LLC | $235.05 | 2024-2025 | Zepbound, Mounjaro, Jardiance |
| Abbott Laboratories | $107.33 | 2023 | Diamondback Coronary |
| Vertex Pharmaceuticals Incorporated | $58.12 | 2024-2025 | |
| Lexington Medical, INC. | $47.81 | 2025 | Aeon Endostapler & Echelon Flex Powered Stapler |
| Ethicon US, LLC | $19.85 | 2025 | Echelon Flex |
| Takeda Pharmaceuticals U.S.A., INC. | $17.18 | 2023 | Gattex |
| Boston Scientific Corporation | $16.52 | 2025 | Spyglass Discover |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Paul Salem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.